ALVO - Alvotech


3.51
-0.110   -3.134%

Share volume: 650,681
Last Updated: 04-21-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.21%

PREVIOUS CLOSE
CHG
CHG%

$3.62
-0.11
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
-2.77%
1 Month
5.41%
3 Months
-32.11%
6 Months
-57.35%
1 Year
-58.01%
2 Year
-73.67%
Key data
Stock price
$3.51
P/E Ratio 
0.00
DAY RANGE
$3.51 - $3.72
EPS 
N/A
52 WEEK RANGE
$3.03 - $11.85
52 WEEK CHANGE
-$58.01
MARKET CAP 
2.854 B
YIELD 
N/A
SHARES OUTSTANDING 
301.482 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-14-2025
BETA 
0.54
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$289,203
AVERAGE 30 VOLUME 
$447,271
Company detail
CEO: Mark L. PhD
Region: US
Website: alvotech.com
Employees: 4
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

N/A

Recent news